Stock ENBI ENTHEON BIOMEDICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Market Closed - Canadian Securities Exchange
Other stock markets
 07:00:00 30/04/2024 pm IST 		5-day change 1st Jan Change
0.165 CAD -.--% Intraday chart for Entheon Biomedical Corp. -17.50% +65.00%
29/04 Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
18/04 Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2021
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
Entheon Biomedical Corp. Announces Enrollment in Phase 1 Study of DMT
Entheon Biomedical Corp. Announces EBIQ-101 First-Patient Dose
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study
Entheon Biomedical Corp. Announces the Approval of DMT Clinical Trial
Entheon Biomedical Corp. Announces the Submission of the Regulatory Package for Its Upcoming Phase 1 Clinical Trial
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. News Entheon Biomedical Corp.
  5. Other languages